Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C742414-100 100 µg (0.5 mg/ml) $503 
FBXO11 Antibody - Goat anti-FBXO11 (aa754-765) Antibody (0.1µg/ml) staining of nuclear HeLa (A) and A431 (B) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescencence.
FBXO11 Antibody - Antibody (0.1µg/ml) staining of nuclear HeLa (A) and A431 (B) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
FBXO11 Antibody - Goat anti-FBXO11 (aa754-765) Antibody (0.1µg/ml) staining of nuclear HeLa (A) and A431 (B) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescencence.
FBXO11 Antibody - Antibody (0.1µg/ml) staining of nuclear HeLa (A) and A431 (B) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
1 of 2
2 of 2

Polyclonal Goat anti‑Human FBXO11 Antibody (aa754‑765, WB) LS‑C742414

Polyclonal Goat anti‑Human FBXO11 Antibody (aa754‑765, WB) LS‑C742414

Antibody:
FBXO11 Goat anti-Human Polyclonal (aa754-765) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$503
LS-C742414-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
FBXO11 Goat anti-Human Polyclonal (aa754-765) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
FBXO11 antibody LS-C742414 is an unconjugated goat polyclonal antibody to human FBXO11 (aa754-765). Validated for Peptide-ELISA and WB.
Target
Human FBXO11
Synonyms
FBXO11 | F-box only protein 11 | F-box protein 11 | FBX11 | PRMT9 | UG063H01 | VIT1 | VIT-1 | UBR6 | Vitiligo-associated protein 1
Host
Goat
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Modifications
Unmodified
Immunogen
Peptide with sequence C-KISSYTSYPMHD, from the internal region of the protein sequence according to NP_079409.3NP_001177203.1NP_IDNP_IDNP_IDNP_ID.
Epitope
aa754-765
Specificity
This antibody is expected to recognize all reported isoforms (NP_079409.3; NP_001177203.1; XP_005264629.1; XP_005264630.1; XP_005264631.1; XP_005264632.1).
Applications
  • Western blot (0.1 - 0.3 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:16000)
Usage
Peptide ELISA: antibody detection limit dilution 1:16000. Western blot: Approx 90kDa band observed in nuclear lysates of cell line HeLa and lysates of cell line A431 (calculated MW of 94.1kDa according to NP_079409.3). Recommended concentration: 0.1-0.3 ug/ml. Primary incubation 1 hour at room temperature.
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About FBXO11
Q86XK2 NM_025133 NP_079409.3

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/25/2024